Shanghai Pharmaceuticals Holding Co Ltd (SHPMY)
7.915
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Shanghai Pharmaceuticals Total Assets (Quarterly): 30.55B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 30.55B |
| December 31, 2023 | 29.90B |
| September 30, 2023 | 29.21B |
| June 30, 2023 | 29.41B |
| June 30, 2023 | 29.41B |
| March 31, 2023 | 29.94B |
| December 31, 2022 | 28.72B |
| September 30, 2022 | 27.31B |
| June 30, 2022 | 27.93B |
| June 30, 2022 | 27.93B |
| March 31, 2022 | 28.63B |
| December 31, 2021 | 25.64B |
| September 30, 2021 | 25.23B |
| June 30, 2021 | 24.50B |
| June 30, 2021 | 24.50B |
| March 31, 2021 | 23.71B |
| December 31, 2020 | 22.83B |
| September 30, 2020 | 21.81B |
| June 30, 2020 | 20.86B |
| June 30, 2020 | 20.86B |
| March 31, 2020 | 19.87B |
| December 31, 2019 | 19.58B |
| September 30, 2019 | 19.04B |
| June 30, 2019 | 19.44B |
| June 30, 2019 | 19.44B |
| Date | Value |
|---|---|
| March 31, 2019 | 20.03B |
| December 31, 2018 | 18.44B |
| September 30, 2018 | 18.13B |
| June 30, 2018 | 17.96B |
| June 30, 2018 | 17.96B |
| March 31, 2018 | 18.14B |
| December 31, 2017 | 14.45B |
| September 30, 2017 | 13.80B |
| June 30, 2017 | 13.34B |
| June 30, 2017 | 13.34B |
| March 31, 2017 | 12.90B |
| December 31, 2016 | 11.91B |
| September 30, 2016 | 12.13B |
| June 30, 2016 | 11.91B |
| June 30, 2016 | 11.91B |
| March 31, 2016 | 12.03B |
| December 31, 2015 | 11.45B |
| September 30, 2015 | 11.39B |
| June 30, 2015 | 11.25B |
| June 30, 2015 | 11.25B |
| March 31, 2015 | 10.84B |
| December 31, 2014 | 10.37B |
| September 30, 2014 | 10.52B |
| June 30, 2014 | 10.15B |
| June 30, 2014 | 10.15B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
19.04B
Minimum
Sep 2019
30.55B
Maximum
Mar 2024
25.05B
Average
25.23B
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 13.66B |
| CASI Pharmaceuticals Inc | 75.27M |
| Zai Lab Ltd | 988.44M |
| Gracell Biotechnologies Inc (DELISTED) | 259.03M |
| Adagene Inc | 115.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.02B |
| Shareholders Equity (Quarterly) | 9.845B |
| Debt to Equity Ratio | 0.6794 |
| Current Ratio | 1.336 |
| Net Debt Paydown Yield | -4.78% |